financetom
Business
financetom
/
Business
/
Update: Exelixis Shares Rise After Higher Q2 Results
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Exelixis Shares Rise After Higher Q2 Results
Aug 7, 2024 9:54 AM

12:36 PM EDT, 08/07/2024 (MT Newswires) -- (Updates with stock move in the headline and first paragraph.)

Exelixis ( EXEL ) shares advanced nearly 15% in recent Wednesday trading after the company reported Q2 non-GAAP diluted earnings late Tuesday of $0.84 a share, up from $0.31 a year earlier.

Analysts surveyed by Capital IQ expected $0.37.

Revenue for the quarter ended June 30 was $637.2 million, up from $469.8 million a year earlier.

Analysts polled by Capital IQ expected $465.1 million.

The company now expects fiscal 2024 revenue of $1.98 billion to $2.08 billion. It previously expected $1.83 billion to $1.93 billion of revenues.

Analysts surveyed by Capital IQ expect $1.88 billion.

Price: 26.94, Change: +3.49, Percent Change: +14.88

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
SL Green Announces Series of Transactions at 1552-1560 Broadway
SL Green Announces Series of Transactions at 1552-1560 Broadway
Sep 22, 2025
NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- SL Green Realty Corp. ( SLG/PI ) , Manhattan’s largest office landlord, today announced that it has completed two transactions at 1552-1560 Broadway, the flagship retail location located in the heart of the Times Square bow tie. In June, SL Green, with its joint venture partner, Jeff’s Sutton’s Wharton Properties, acquired the...
Pfizer Agrees to Acquire Metsera in $4.9 Billion Cash Deal
Pfizer Agrees to Acquire Metsera in $4.9 Billion Cash Deal
Sep 22, 2025
07:28 AM EDT, 09/22/2025 (MT Newswires) -- Pfizer ( PFE ) said Monday it has entered into a definitive agreement to acquire Metsera ( MTSR ) for $47.50 per share in cash, valuing the company at about $4.9 billion. The acquisition will add differentiated oral and injectable incretin, non-incretin and combination therapy candidates to its pipeline. The agreement, unanimously approved...
TomaGold Announces Amendments to Mining Property Option Agreements
TomaGold Announces Amendments to Mining Property Option Agreements
Sep 22, 2025
MONTREAL--(BUSINESS WIRE)-- TOMAGOLD CORPORATION ( TOGOF ) (“TomaGold ( TOGOF )” or the “Company”) announces that it has entered into amendments (the “Amending Agreements”) with Chibougamau Independent Mines Inc. ( CMAUF ) (“CIM”) and Globex Mining Enterprises Inc. ( GLBXF ) (“Globex”), to the option agreements dated August 11, 2023, as amended, pursuant to which the Company has the right...
V2X Completes Acquisition of QinetiQ U.S. Intelligence Business, Expanding National Security Capabilities
V2X Completes Acquisition of QinetiQ U.S. Intelligence Business, Expanding National Security Capabilities
Sep 22, 2025
RESTON, Va., Sept 22, 2025 /PRNewswire/ -- V2X, Inc. ( VVX ) today announced the successful completion of its acquisition of QinetiQ's U.S. Intelligence business, a provider of data engineering, intelligence mission support, and cyber solutions for the Intelligence Community. The transaction, valued at approximately $24 million net of estimated tax benefits, adds new capabilities and expands V2X's access to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved